FDA Approved: PACERONE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for PACERONE (amiodarone hydrochloride) from Upsher-Smith Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• PACERONE (AMIODARONE HYDROCHLORIDE)

Snippet

SUPPL AP for PACERONE (AMIODARONE HYDROCHLORIDE)